Fibroids tend to grow in an estrogenic environment. When estrogen levels are low, either because of ovarian failure or a medically induced hypoestrogenic state, fibroid size is reduced and symptoms ...
New data indicate that administration of a gonadotropin-releasing hormone analogue did not maintain ovarian function in women at risk for developing ovarian insufficiency related to breast cancer ...
This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a full text component.
Most transgender boys reach their predicted adult height after treatment with gonadotropin-releasing hormone analogues and testosterone therapy, according to data published in The Journal of Clinical ...
Depot leuprolide acetate, a gonadotropin-releasing hormone (GnRH) analogue, protects against premature ovarian failure (POF) in women receiving cyclophosphamide for systemic lupus erythematosus (SLE), ...
Fibroids are benign tumors originating from uterine small muscles. They can be solitary or multiple and can grow towards the uterine cavity or towards the abdominal cavity. They may produce symptoms ...
England's National Health Service banned the use of puberty blockers for children seeking treatment for gender dysphoria, citing limited research. Puberty blockers, or gonadotropin-releasing hormone ...
In 1977, the Nobel Prize in Physiology or Medicine was awarded to Roger Guillemin and Andrew Schally for their discovery and synthesis of gonadotropin-releasing hormone (GnRH), a key regulator of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback